World Opportunity Investor
James DiGeorgia Michael London

Special Reports

[Special Report #007]

#007: 10/15/2017

Good Morning Wall Street: Sneak Peek

Here's on of the world's best institutional analysts run down on the U.S. Stock Market. Focusing on sentiment, Phil Errlanger take on the market is one of the most accurate available. ~more~

[Special Report #006]

#006: 07/01/2017

Tom McClellan warns: "Treasury-Bund Spread Gives Early Warning of the End" of Bull Market on Wall Street

Tom McClellan in my opinion is one of the best market timers in the world for stocks, commodities and currencies. This week he issued this special update regarding the current bull market on Wall Street. It's going to end. Not now but soon. ~more~

[Special Report #005]

#005: 02/13/2017

Science Fiction Discoveries That Could Make You Rich

Five companies with disruptive technologies that sound like they’re right out of the pages of a science fiction novel ... but are actually much closer to reality than most investors realize. ~more~

[Special Report #004]

#004: 02/01/2017

Cleaning Up with Pura Naturals Revolutionary Sponges!

Why I believe Pura Naturals’shares have the potential to hand shareholders up to a 686% gain over the next 4 years.* ~more~

[Special Report #003]

#003: 01/17/2017

Serial Killer - 3 Companies on the Verge of Curing Cancer That Could Be Commercialized in the Next 48 Months

Get ready for some incredible breakthroughs in medicine and science that will change the world we live in for the better. ~more~

[Special Report #002]

#002: 01/13/2017

7 Secrets for Finding Stocks That Soar

They can also be used to find stocks that are going to Plummet! ~more~

[Special Report #001]

#001: 01/11/2017

Unclogging the Brain – 3 Companies Heading Towards Alzheimer's Cure

Alzheimer’s disease is one of the most frightening diseases because the cause is still really unknown in most cases. According to current research, fewer than 5 percent of cases of Alzheimer's are linked to specific, rare gene mutations. Those suffering from the disease as a result of rare genetic mutations are usually early-onset cases that develop in middle age. ~more~